Elizabeth Barrett
Chief Executive Officer at UROGEN PHARMA LTD.
Net worth: 4 M $ as of 31/05/2024
Elizabeth Barrett active positions
Companies | Position | Start | End |
---|---|---|---|
UROGEN PHARMA LTD. | Director/Board Member | 03/01/2019 | - |
Chief Executive Officer | 03/01/2019 | - | |
President | 03/01/2019 | - | |
SAGE THERAPEUTICS, INC. | Director/Board Member | 23/01/2019 | - |
Independent Dir/Board Member | 23/01/2019 | - | |
ALLOGENE THERAPEUTICS, INC. | Director/Board Member | 30/07/2021 | - |
Independent Dir/Board Member | 30/07/2021 | - | |
UroGen Pharma, Inc. | Chief Executive Officer | 01/01/2019 | - |
President | 01/01/2019 | - |
Career history of Elizabeth Barrett
Former positions of Elizabeth Barrett
Companies | Position | Start | End |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 24/03/2009 | 01/01/2019 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Chief Executive Officer | 01/02/2018 | 01/01/2019 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01/01/2006 | 01/01/2009 |
SCIENCE 37 HOLDINGS, INC. | Director/Board Member | 23/11/2020 | - |
Independent Dir/Board Member | 23/11/2020 | - | |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
Training of Elizabeth Barrett
St. Joseph's University | Masters Business Admin |
University of Louisiana at Lafayette | Undergraduate Degree |
Statistics
International
United States | 15 |
Operational
Corporate Officer/Principal | 4 |
Chief Executive Officer | 4 |
Director/Board Member | 4 |
Sectoral
Health Technology | 11 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 5 |
---|---|
PFIZER, INC. | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
ALLOGENE THERAPEUTICS, INC. | Health Technology |
Private companies | 7 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Veridex LLC
Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Health Technology |
Ortho Biotech, Inc. | |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Lifesci Acquisition II Corp.
Lifesci Acquisition II Corp. Financial ConglomeratesFinance LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York, NY. | Finance |
UroGen Pharma, Inc. | Health Technology |
- Stock Market
- Insiders
- Elizabeth Barrett
- Experience